NCT01217775View on ClinicalTrials.gov

Intranasal PH80 Spray for Acute Management of the Symptoms of Premenstrual Dysphoric Disorder

PHASE3UnknownINTERVENTIONAL
Enrollment

1,400

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

March 31, 2017

Study Completion Date

July 31, 2017

Conditions
Premenstrual Dysphoric Disorder
Interventions
DRUG

PH80

PH80 intranasal spray 800 nanograms

DRUG

Placebo intranasal spray

Placebo intranasal spray

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

Sponsors
All Listed Sponsors
lead

Pherin Pharmaceuticals, Inc.

INDUSTRY